Skip to content

In the BioHarmony Drug Report Database

Moroctocog alfa

ReFacto AF (moroctocog alfa) is a protein pharmaceutical. Moroctocog alfa was first approved as ReFacto AF on 1999-04-13. It has been approved in Europe to treat hemophilia a.
Trade Name ReFacto AF
Common Name Moroctocog alfa
Indication hemophilia a
Drug Class
Moroctocog alfa
Get full access now